Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms

被引:47
|
作者
Bhateja, Deepak Kumar [1 ]
Dhull, Dinesh K. [1 ]
Gill, Aneet [1 ]
Sidhu, Akramdeep [1 ]
Sharma, Saurabh [1 ]
Reddy, B. V. Krishna [1 ]
Padi, Satyanarayana S. V. [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Neuropharmacol Div, Moga 142001, Punjab, India
关键词
Fenofibrate; Huntington's disease; MK886; 3-nitropropionic acid; Oxidative stress; NF-KAPPA-B; PPAR-ALPHA; OXIDATIVE STRESS; MICROGLIAL ACTIVATION; MITOCHONDRIAL TOXIN; HUNTINGTONS-DISEASE; STRIATAL DEGENERATION; EXPERIMENTAL-MODEL; SPINAL-CORD; CELL-DEATH;
D O I
10.1016/j.ejphar.2011.10.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferators activated receptor is regarded as potential therapeutic targets to control various neurodegenerative disorders. However, none of the study has elucidated its effect in the treatment of Huntington's disease. We explored whether peroxisome proliferators activated receptor-a agonist may attenuate various behavioral and biochemical alterations induced by systemic administration of 3-nitropropionic acid (3-NP), an accepted experimental animal model of Huntington's disease phenotype. Intraperitoneal administration of 3-NP (20 mg/kg., i.p.) for 4 days in rats produced hypolocomotion, muscle incoordination, and cognitive dysfunction. Daily treatment with fenofibrate (100 or 200 mg/kg., p.o.), 30 min prior to 3-NP administration for a total of 4 days, significantly improved the 3-NP induced motor and cognitive impairment. Biochemical analysis revealed that systemic 3-NP administration significantly increased oxidative and nitrosative stress (increase lipid peroxidation, protein carbonyls and nitrite level), lactate dehydrogenase activity whereas, decreased the activities of catalase, superoxide dismutase, reduced glutathione, and succinate dehydrogenase. Fenofibrate treatment significantly attenuated oxidative damage, cytokines and improved mitochondrial complexes enzyme activity in brain. In the present study, MK886, a selective inhibitor of peroxisome proliferators activated receptor-a was employed to elucidate the beneficial effect through either receptor dependent or receptor independent neuroprotective mechanisms. Administration of MK886 (1 mg/kg, i.p.) prior to fenofibrate (200 mg/kg, p.o.) abolished the effect of fenofibrate. The results showed that receptor dependent neuroprotective effects of fenofibrate in 3-NP administered rats provide a new evidence for a role of PPAR-a activation in neuroprotection that is attributed by modulating oxidative stress and inflammation. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 50 条
  • [31] Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats
    Mirza, Roohi
    Sharma, Bhupesh
    LIFE SCIENCES, 2018, 214 : 106 - 117
  • [32] Neuroprotective Effect of Lutein Against 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms: Possible Behavioral, Biochemical, and Cellular Alterations
    Binawade, Yogita
    Jagtap, Aarti
    JOURNAL OF MEDICINAL FOOD, 2013, 16 (10) : 934 - 943
  • [33] Sinapic acid attenuates cisplatin-induced nephrotoxicity through peroxisome proliferator-activated receptor gamma agonism in rats
    Singh, Hardevinder Pal
    Singh, Thakur Gurjeet
    Singh, Randhir
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2020, 12 (02): : 146 - 154
  • [34] Impacts of peroxisome proliferator-activated receptor-γ activation on cigarette smoke-induced exacerbated response to bacteria
    Morissette, Mathieu C.
    Shen, Pamela
    Thayaparan, Danya
    Staempfli, Martin R.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (01) : 191 - 200
  • [35] Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5
    Romero, Miguel
    Jimenez, Rosario
    Toral, Marta
    Leon-Gomez, Elvira
    Gomez-Guzman, Manuel
    Sanchez, Manuel
    Jose Zarzuelo, Maria
    Rodriguez-Gomez, Isabel
    Rath, Geraldine
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Dessy, Chantal
    Duarte, Juan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (01): : 151 - 163
  • [36] Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone
    Enomoto, N
    Takei, Y
    Hirose, M
    Konno, A
    Shibuya, T
    Matsuyama, S
    Suzuki, S
    Ikejima, K
    Kitamura, T
    Sato, N
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03): : 846 - 854
  • [37] Role of peroxisome proliferator-activated receptor a activation in acute myocardial damage induced by isoproterenol in rats
    Yuan Jie
    Wu Jian
    Hang Zhi-gang
    Zhong Xue-kuan
    Zhou Ling-wang
    Yu Bo
    CHINESE MEDICAL JOURNAL, 2008, 121 (16) : 1569 - 1573
  • [38] Activation of peroxisome proliferator-activated receptor-α prevents glycogen synthase 3β phosphorylation and inhibits cardiac hypertrophy
    Li, Ruifang
    Zheng, Wenhua
    Pi, Rongbiao
    Gao, Jie
    Zhang, Huijie
    Le, Ping Wang Kang
    Liu, Peiqing
    FEBS LETTERS, 2007, 581 (17) : 3311 - 3316
  • [39] Caffeic Acid Inhibits UVB-induced Inflammation and Photocarcinogenesis Through Activation of Peroxisome Proliferator-activated Receptor- in Mouse Skin
    Balupillai, Agilan
    Prasad, Rajendra N.
    Ramasamy, Karthikeyan
    Muthusamy, Ganesan
    Shanmugham, Mohana
    Govindasamy, Kanimozhi
    Gunaseelan, Srithar
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2015, 91 (06) : 1458 - 1468
  • [40] Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-γ activation after stress in rats
    Garcia-Bueno, Borja
    Madrigal, Jose L. M.
    Perez-Nievas, Beatriz G.
    Leza, Juan Carlos
    ENDOCRINOLOGY, 2008, 149 (04) : 1969 - 1978